Cagrilintide 10mg

"Significant Weight Loss: Clinical trials (REDEFINE 1) demonstrated that 2.4-mg doses of cagrilintide resulted in a 11.8% reduction in body weight compared to 2.3% for a placebo.

Enhanced Appetite Suppression: By mimicking the hormone amylin, it increases satiety and reduces cravings, leading to lower caloric intake.

Improved Glycemic Control: It helps manage blood sugar levels, making it beneficial for treating type 2 diabetes and reducing hemoglobin A1c (HbA1c).

Cardiometabolic Health Improvements: Studies indicate improvements in blood pressure, lipid profiles, and reductions in C-reactive protein (an inflammatory marker).

Synergy with Semaglutide (CagriSema): Combining cagrilintide with semaglutide resulted in up to 20.4% body weight reduction in trials, which is considered a potential alternative to bariatric surgery."